Trademark Attorney / Law Firm
CHARLES A. HAASE – Trademark Portfolio
CHARLES A. HAASE specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 4 of 8 total filings concentrated in this category. The practice also covers Class 37 (Building & Construction) along with 5 other Nice Classification classes. Filing activity spans from 1983 to 1988. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
CHARLES A. HAASE's trademark practice covers 5 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademark applications has CHARLES A. HAASE filed?
CHARLES A. HAASE has filed 8 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does CHARLES A. HAASE specialize in?
CHARLES A. HAASE has filed trademarks across 5 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 37 (Building & Construction), Class 1 (Chemicals), Class 27 (Floor Coverings), Class 17 (Rubber Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has CHARLES A. HAASE been filing trademarks?
CHARLES A. HAASE's trademark filing history with the USPTO spans from 1983 to 1988, covering 5 years of trademark practice. During this period, CHARLES A. HAASE has handled 8 trademark applications.
What is CHARLES A. HAASE's trademark registration success rate?
CHARLES A. HAASE has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.